Massachusetts General Hospital: Hypersensitivity trials

The registry lists 11 Hypersensitivity studies with Massachusetts General Hospital as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 6Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Omalizumab Weight-Based Dosing Efficacy TrialRecruitingNCT06943534Phase 2
• Optimizing the Diagnostic Approach to Cephalosporin Allergy TestingRecruitingNCT06406114Phase 2
• VE416 for Treatment of Food AllergyRecruitingNCT03936998Phase 1/2
• Effects of Pitavastatin on Insulin Sensitivity and Liver FatCompletedNCT02290106Not applicableResults posted
• Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-TreatmentTerminatedNCT02035345Phase 4Results posted
• Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal CancerCompletedNCT01188876Phase 1/2Results posted
• Impact of Infant Formula on Resolution of Cow's Milk AllergyTerminatedNCT02719405Phase 2
• Using Spectrally Encoded Confocal Microscopy (SECM) to Image the EsophagusActive, not recruitingNCT02202590Not applicable
• Effectiveness of Telepsychiatry-based Culturally Sensitive Collaborative Treatment of Depressed Chinese AmericansCompletedNCT00854542Not applicable
• Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer SurvivorsCompletedNCT00738140Phase 2
• Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate CancerCompletedNCT00456144